Insider · CIK 1698310
Sean Maduck
Corcept Therapeutics CORT
Full history from EDGAR: holdings now, every transaction and Form 144 planned sales
Open-market buys0
Open-market sales75
Bought$0
Sold$62.9M
Every trade, with what the company filed around it
Open-market buys and sales as each Form 4 states them, newest first.
How these figures work
Notes on each row are as each Form 4 states them, next to SEC Tracker's own records of the company's filings and other insiders' buys. Holding after is what the filing reports they held after the trade, with the change in their holding.
| Date | Company | Trade | Value | Holding after | Notes |
|---|---|---|---|---|---|
| Nov 3, 2026 | Corcept Therapeutics CORT | Sold (10b5-1) 8,617 sh at $82.02 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Nov 3, 2026. | $707K | 14,480 −37% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Nov 3, 2026. |
| Nov 3, 2026 | Corcept Therapeutics CORT | Sold (10b5-1) 4,542 sh at $82.68 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Nov 3, 2026. | $376K | 9,938 −31% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Nov 3, 2026. |
| Nov 2, 2026 | Corcept Therapeutics CORT | Sold (10b5-1) 11,841 sh at $81.42 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after the company's SCHEDULE 13G/A filed Oct 27, 2026. | $964K | 9,938 −54% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after the company's SCHEDULE 13G/A filed Oct 27, 2026. |
| Oct 2, 2026 | Corcept Therapeutics CORT | Sold (10b5-1) 15,843 sh at $116.12 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after a Form 144 notice of a planned insider sale filed Oct 1, 2026. | $1.8M | 18,682 −46% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after a Form 144 notice of a planned insider sale filed Oct 1, 2026. |
| Oct 2, 2026 | Corcept Therapeutics CORT | Sold (10b5-1) 8,744 sh at $116.55 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after a Form 144 notice of a planned insider sale filed Oct 1, 2026. | $1M | 9,938 −47% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after a Form 144 notice of a planned insider sale filed Oct 1, 2026. |
| Oct 1, 2026 | Corcept Therapeutics CORT | Sold (10b5-1) 413 sh at $115.54 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 1, 2026. | $48K | 9,938 −4% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 1, 2026. |
| Sep 1, 2026 | Corcept Therapeutics CORT | Sold (10b5-1) 11,730 sh at $113.94 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after a Form 144 notice of a planned insider sale filed Aug 26, 2026. | $1.3M | 23,025 −34% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after a Form 144 notice of a planned insider sale filed Aug 26, 2026. |
| Sep 1, 2026 | Corcept Therapeutics CORT | Sold (10b5-1) 10,989 sh at $114.71 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after a Form 144 notice of a planned insider sale filed Aug 26, 2026. | $1.3M | 12,036 −48% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after a Form 144 notice of a planned insider sale filed Aug 26, 2026. |
| Sep 1, 2026 | Corcept Therapeutics CORT | Sold (10b5-1) 2,281 sh at $115.61 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after a Form 144 notice of a planned insider sale filed Aug 26, 2026. | $264K | 9,755 −19% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after a Form 144 notice of a planned insider sale filed Aug 26, 2026. |
| Aug 25, 2026 | Corcept Therapeutics CORT | Sold (10b5-1) 25,085 sh at $125.47 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Aug 25, 2026. | $3.1M | 15,625 −62% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Aug 25, 2026. |
| Aug 25, 2026 | Corcept Therapeutics CORT | Sold (10b5-1) 5,870 sh at $126.06 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Aug 25, 2026. | $740K | 9,755 −38% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Aug 25, 2026. |
| Aug 14, 2026 | Corcept Therapeutics CORT | Sold (10b5-1) 3,664 sh at $114.49 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after the company's SCHEDULE 13G/A filed Aug 13, 2026. | $419K | 9,755 −27% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after the company's SCHEDULE 13G/A filed Aug 13, 2026. |
| Aug 10, 2026 | Corcept Therapeutics CORT | Sold (10b5-1) 1,031 sh at $114.52 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after a Form 144 notice of a planned insider sale filed Aug 4, 2026. | $118K | 9,755 −10% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after a Form 144 notice of a planned insider sale filed Aug 4, 2026. |
| Aug 3, 2026 | Corcept Therapeutics CORT | Sold (10b5-1) 20,305 sh at $114.70 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Aug 3, 2026. | $2.3M | 9,755 −68% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Aug 3, 2026. |
| Jul 1, 2026 | Corcept Therapeutics CORT | Sold (10b5-1) 11,024 sh at $87.33 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 14 days after the company's 8-K filed Jun 17, 2026. | $963K | 23,731 −32% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 14 days after the company's 8-K filed Jun 17, 2026. |
| Jul 1, 2026 | Corcept Therapeutics CORT | Sold (10b5-1) 2,801 sh at $88.51 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 14 days after the company's 8-K filed Jun 17, 2026. | $248K | 20,930 −12% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 14 days after the company's 8-K filed Jun 17, 2026. |
| Jul 1, 2026 | Corcept Therapeutics CORT | Sold (10b5-1) 11,175 sh at $89.31 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 14 days after the company's 8-K filed Jun 17, 2026. | $998K | 9,755 −53% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 14 days after the company's 8-K filed Jun 17, 2026. |
| Jun 1, 2026 | Corcept Therapeutics CORT | Sold (10b5-1) 21,069 sh at $70.11 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Jun 1, 2026. | $1.5M | 12,908 −62% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Jun 1, 2026. |
| Jun 1, 2026 | Corcept Therapeutics CORT | Sold (10b5-1) 3,931 sh at $70.75 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Jun 1, 2026. | $278K | 8,977 −30% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Jun 1, 2026. |
| May 27, 2026 | Corcept Therapeutics CORT | Sold (10b5-1) 54,575 sh at $65.37 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed May 27, 2026. | $3.6M | 29,402 −65% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed May 27, 2026. |
| May 27, 2026 | Corcept Therapeutics CORT | Sold (10b5-1) 20,425 sh at $66.16 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed May 27, 2026. | $1.4M | 8,977 −69% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed May 27, 2026. |
| Dec 1, 2025 | Corcept Therapeutics CORT | Sold (10b5-1) 20,000 sh at $79.52 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Dec 1, 2025. | $1.6M | 7,904 −72% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Dec 1, 2025. |
| Nov 3, 2025 | Corcept Therapeutics CORT | Sold (10b5-1) 20,000 sh at $73.99 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Nov 3, 2025. | $1.5M | 7,904 −72% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Nov 3, 2025. |
| Oct 1, 2025 | Corcept Therapeutics CORT | Sold (10b5-1) 959 sh at $83.73 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 1, 2025. | $80K | 26,945 −3% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 1, 2025. |
| Oct 1, 2025 | Corcept Therapeutics CORT | Sold (10b5-1) 16,394 sh at $85.06 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 1, 2025. | $1.4M | 10,551 −61% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 1, 2025. |
| Oct 1, 2025 | Corcept Therapeutics CORT | Sold (10b5-1) 2,647 sh at $85.58 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 1, 2025. | $227K | 7,904 −25% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 1, 2025. |
| Sep 2, 2025 | Corcept Therapeutics CORT | Sold (10b5-1) 15,070 sh at $70.38 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Sep 2, 2025. | $1.1M | 12,611 −54% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Sep 2, 2025. |
| Sep 2, 2025 | Corcept Therapeutics CORT | Sold (10b5-1) 4,930 sh at $70.84 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Sep 2, 2025. | $349K | 7,681 −39% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Sep 2, 2025. |
| Aug 1, 2025 | Corcept Therapeutics CORT | Sold (10b5-1) 27,865 sh at $67.53 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Aug 1, 2025. | $1.9M | 14,823 −65% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Aug 1, 2025. |
| Aug 1, 2025 | Corcept Therapeutics CORT | Sold (10b5-1) 5,428 sh at $68.52 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Aug 1, 2025. | $372K | 9,395 −37% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Aug 1, 2025. |
| Aug 1, 2025 | Corcept Therapeutics CORT | Sold (10b5-1) 1,714 sh at $69.70 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Aug 1, 2025. | $119K | 7,681 −18% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Aug 1, 2025. |
| Jul 18, 2025 | Corcept Therapeutics CORT | Sold (10b5-1) 473 sh at $73.44 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 63 days after a Form 144 notice of a planned insider sale filed May 16, 2025. | $35K | 17,705 −3% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 63 days after a Form 144 notice of a planned insider sale filed May 16, 2025. |
| Jul 17, 2025 | Corcept Therapeutics CORT | Sold (10b5-1) 4,315 sh at $73.48 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 62 days after a Form 144 notice of a planned insider sale filed May 16, 2025. | $317K | 17,705 −20% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 62 days after a Form 144 notice of a planned insider sale filed May 16, 2025. |
| Jul 1, 2025 | Corcept Therapeutics CORT | Sold (10b5-1) 205 sh at $73.45 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 46 days after a Form 144 notice of a planned insider sale filed May 16, 2025. | $15K | 17,705 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 46 days after a Form 144 notice of a planned insider sale filed May 16, 2025. |
| Jun 2, 2025 | Corcept Therapeutics CORT | Sold (10b5-1) 5,752 sh at $77.91 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 17 days after a Form 144 notice of a planned insider sale filed May 16, 2025. | $448K | 31,953 −15% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 17 days after a Form 144 notice of a planned insider sale filed May 16, 2025. |
| Jun 2, 2025 | Corcept Therapeutics CORT | Sold (10b5-1) 6,191 sh at $78.87 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 17 days after a Form 144 notice of a planned insider sale filed May 16, 2025. | $488K | 25,762 −19% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 17 days after a Form 144 notice of a planned insider sale filed May 16, 2025. |
| Jun 2, 2025 | Corcept Therapeutics CORT | Sold (10b5-1) 6,246 sh at $79.89 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 17 days after a Form 144 notice of a planned insider sale filed May 16, 2025. | $499K | 19,516 −24% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 17 days after a Form 144 notice of a planned insider sale filed May 16, 2025. |
| Jun 2, 2025 | Corcept Therapeutics CORT | Sold (10b5-1) 1,811 sh at $80.77 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 17 days after a Form 144 notice of a planned insider sale filed May 16, 2025. | $146K | 17,705 −9% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 17 days after a Form 144 notice of a planned insider sale filed May 16, 2025. |
| May 2, 2025 | Corcept Therapeutics CORT | Sold (10b5-1) 25,847 sh at $72.21 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 9 days after the company's SCHEDULE 13G/A filed Apr 23, 2025. | $1.9M | 86,329 −23% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 9 days after the company's SCHEDULE 13G/A filed Apr 23, 2025. |
| May 2, 2025 | Corcept Therapeutics CORT | Sold (10b5-1) 707 sh at $72.98 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 9 days after the company's SCHEDULE 13G/A filed Apr 23, 2025. | $52K | 85,622 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 9 days after the company's SCHEDULE 13G/A filed Apr 23, 2025. |
| May 1, 2025 | Corcept Therapeutics CORT | Sold (10b5-1) 12,856 sh at $71.94 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 8 days after the company's SCHEDULE 13G/A filed Apr 23, 2025. | $925K | 85,622 −13% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 8 days after the company's SCHEDULE 13G/A filed Apr 23, 2025. |
| Apr 1, 2025 | Corcept Therapeutics CORT | Sold (10b5-1) 590 sh at $114.55 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Apr 1, 2025. | $68K | 85,622 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Apr 1, 2025. |
| Mar 31, 2025 | Corcept Therapeutics CORT | Sold (10b5-1) 79,277 sh at $100.26 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Mar 31, 2025. | $7.9M | 106,345 −43% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Mar 31, 2025. |
| Mar 31, 2025 | Corcept Therapeutics CORT | Sold (10b5-1) 15,133 sh at $101.43 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Mar 31, 2025. | $1.5M | 91,212 −14% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Mar 31, 2025. |
| Mar 31, 2025 | Corcept Therapeutics CORT | Sold (10b5-1) 5,590 sh at $102.16 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Mar 31, 2025. | $571K | 85,622 −6% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Mar 31, 2025. |
| Mar 24, 2025 | Corcept Therapeutics CORT | Sold (10b5-1) 1,697 sh at $60.58 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 21 days after the company's 8-K filed Mar 3, 2025. | $103K | 85,622 −2% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 21 days after the company's 8-K filed Mar 3, 2025. |
| Mar 3, 2025 | Corcept Therapeutics CORT | Sold (10b5-1) 18,303 sh at $60.69 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Mar 3, 2025. | $1.1M | 85,622 −18% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Mar 3, 2025. |
| Feb 3, 2025 | Corcept Therapeutics CORT | Sold (10b5-1) 20,000 sh at $66.92 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 32 days after a Form 144 notice of a planned insider sale filed Jan 2, 2025. | $1.3M | 85,318 −19% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 32 days after a Form 144 notice of a planned insider sale filed Jan 2, 2025. |
| Jan 2, 2025 | Corcept Therapeutics CORT | Sold (10b5-1) 20,000 sh at $50.39 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Jan 2, 2025. | $1M | 85,318 −19% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Jan 2, 2025. |
| May 13, 2024 | Corcept Therapeutics CORT | Sold (10b5-1) 50,000 sh at $28.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 87 days after a Form 144 notice of a planned insider sale filed Feb 16, 2024. | $1.4M | 85,222 −37% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 87 days after a Form 144 notice of a planned insider sale filed Feb 16, 2024. |
| Mar 27, 2024 | Corcept Therapeutics CORT | Sold (10b5-1) 25,953 sh at $25.01 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 40 days after a Form 144 notice of a planned insider sale filed Feb 16, 2024. | $649K | 85,222 −23% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 40 days after a Form 144 notice of a planned insider sale filed Feb 16, 2024. |
| Mar 18, 2024 | Corcept Therapeutics CORT | Sold (10b5-1) 17,219 sh at $25.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 31 days after a Form 144 notice of a planned insider sale filed Feb 16, 2024. | $430K | 75,222 −19% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 31 days after a Form 144 notice of a planned insider sale filed Feb 16, 2024. |
| Feb 16, 2024 | Corcept Therapeutics CORT | Sold (10b5-1) 27,068 sh at $25.97 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Feb 16, 2024. | $703K | 74,455 −27% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Feb 16, 2024. |
| Feb 15, 2024 | Corcept Therapeutics CORT | Sold (10b5-1) 4,760 sh at $25.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Feb 15, 2024. | $119K | 74,455 −6% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Feb 15, 2024. |
| Dec 1, 2023 | Corcept Therapeutics CORT | Sold (10b5-1) 25,000 sh at $25.56 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Dec 1, 2023. | $639K | 73,291 −25% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Dec 1, 2023. |
| Nov 2, 2023 | Corcept Therapeutics CORT | Sold (10b5-1) 19,888 sh at $28.11 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $559K | 73,291 −21% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Nov 1, 2023 | Corcept Therapeutics CORT | Sold (10b5-1) 5,112 sh at $28.08 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $144K | 73,291 −7% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Oct 10, 2023 | Corcept Therapeutics CORT | Sold (10b5-1) 18,471 sh at $27.29 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $504K | 73,291 −20% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Oct 6, 2023 | Corcept Therapeutics CORT | Sold (10b5-1) 3,498 sh at $27.24 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $95K | 73,610 −5% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Oct 2, 2023 | Corcept Therapeutics CORT | Sold (10b5-1) 3,031 sh at $27.24 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $83K | 73,610 −4% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Sep 19, 2023 | Corcept Therapeutics CORT | Sold (10b5-1) 25,000 sh at $32.48 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $812K | 73,610 −25% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Dec 1, 2022 | Corcept Therapeutics CORT | Sold (10b5-1) 625 sh at $25.28 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $16K | 56,462 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Nov 10, 2022 | Corcept Therapeutics CORT | Sold (10b5-1) 25,000 sh at $25.57 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $639K | 56,462 −31% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Oct 3, 2022 | Corcept Therapeutics CORT | Sold (10b5-1) 25,000 sh at $25.64 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $641K | 56,462 −31% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Sep 1, 2022 | Corcept Therapeutics CORT | Sold (10b5-1) 25,000 sh at $25.84 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $646K | 54,618 −31% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Aug 9, 2022 | Corcept Therapeutics CORT | Sold (10b5-1) 200 sh at $28.70 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $6K | 40,024 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jul 18, 2022 | Corcept Therapeutics CORT | Sold (10b5-1) 25,000 sh at $27.37 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $684K | 40,024 −38% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Oct 5, 2021 | Corcept Therapeutics CORT | Sold (10b5-1) 637 sh at $20.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $13K | 40,024 −2% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Oct 1, 2021 | Corcept Therapeutics CORT | Sold (10b5-1) 24,363 sh at $20.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $487K | 40,024 −38% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Sep 1, 2021 | Corcept Therapeutics CORT | Sold (10b5-1) 25,000 sh at $21.40 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $535K | 40,024 −38% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Aug 3, 2021 | Corcept Therapeutics CORT | Sold (10b5-1) 25,000 sh at $21.18 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $529K | 40,024 −38% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jul 7, 2021 | Corcept Therapeutics CORT | Sold (10b5-1) 25,000 sh at $22.19 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $555K | 30,024 −45% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Feb 16, 2021 | Corcept Therapeutics CORT | Sold 8,989 sh at $28.25 The filing does not mark this sale as under a Rule 10b5-1 plan. | $254K | 30,024 −23% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Feb 11, 2021 | Corcept Therapeutics CORT | Sold 3,400 sh at $29.78 The filing does not mark this sale as under a Rule 10b5-1 plan. | $101K | 30,024 −10% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Dec 12, 2018 | Corcept Therapeutics CORT | Sold 60,000 sh at $19.01 The filing does not mark this sale as under a Rule 10b5-1 plan. | $1.1M | 20,024 −75% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
Open-market trades are Form 4 transaction codes P (purchase) and S (sale). Planned sales are those the filing marks as made under a Rule 10b5-1 plan. A P-code buy at the offering price within a day of the company's FWP, 424B prospectus or offering 8-K is marked Bought in the offering and left out of open-market buy counts and cluster buys. Prices and values are as stated in each Form 4. Stock prices aren't shown on this page. Not investment advice.